medigraphic.com

2005, Number S1

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2005; 43 (S1)

Impact of the Methods of Preparing Red Cell Concentrates in the Eficiency of Prestorage Leukoreduction Systems

Gómez BF, Gómez RRA, Marín y LRA

Language: Spanish
References: 12
Page: 81-85
PDF size: 129.31 Kb.


Text Extraction

No Abstract


REFERENCES

  1. Heddle NM. Universal leukoreduction and acute transfusion reactions: putting the puzzle together. Transfusion 2004;44:1-4.

  2. Heddle NM, Klama LN, Griffith L, et al. A pros-pective study to identify the risk factors associated with acute reactions to platelet and red cell trans-fusions. Transfusion 1993;33:794-797.

  3. Dzick WH, Anderson JK, O´Neill EM, Assmann SF, Kalish LA and Stowell CP. A prospective, randomized clinical trial of universal WBC reduction. Transfusion 2002;42:1114-1122.

  4. Qu L, Xu S, Rowe D and Triulzi D. Efficacy of Epstein-Barr virus removal by leukoreduction of red blood cells. Transfusion 2005;45:591-595.

  5. Eisenfeld L, Silver H, McLaughlin J, Klevjer-Anderson P, et al. Prevention of transfusion-associated cytomegalo-virus infection in neonatal patients by the removal of white cells from blood. Transfusion 1992;32:205:209.

  6. Shanwell A, Kristiansson M, Remberger M, Ringdén O. Generation of cytokines in red cell concentrates during storage is prevented by prestorage white cell reduction. Transfusion 1997;37:678-684.

  7. Ariga H, Lee TH, Laycock ME, Mohr BA, et al. Resi-dual WBC subsets in filtered prestorage RBCs. Trans-fusion 2003;43:98-106.

  8. Europe Council. Guide to the use, preparation and quality control of blood components. Eleventh edition. Council of Europe Publishing.

  9. Murphy MF. New variant Creutzfeldt-Jacob disease: the risk of transmission by blood transfusion and the potential benefit of leukocyte-reduction of blood components. Transfus Med Rev 1999;13:75-83.

  10. Llewelyn CA, Hewitt PE, Knigth RS, Amar K, Cousens S, et al. Possible transmission of variant Creutzfeldt-Jacob disease by blood transfusion. Lancet 2004; 363:417-421.

  11. Dumont LJ, Disk WH, Rebulla P, Brandwein H, et al. Practical guidelines for process validation and process control of white cell-reduced blood components: report of the Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion (ISBT). Transfusion 1996;36:11-20.

  12. Rodríguez de López LA. Situación internacional de la leucorreducción. Medicina Transfusional al Día 2002;2:2.




2020     |     www.medigraphic.com